PepGen Announces $125 Million Public Stock Offering to Fund Clinical Development
Biotechnology company PepGen (PEPG) has launched a public offering valued at $125 million. The offering consists of common stock and, for certain investors, pre-funded warrants to purchase shares of the company's common stock. The capital raised is intended to support the ongoing clinical development programs of the company. This move aims to strengthen PepGen's balance sheet as it advances its pipeline through necessary regulatory and research milestones.
Tickers: $PEPG
Topics: Common Stock Pre-funded Warrants Public Offering
Read the full article at Seeking Alpha
Part of the story Neuronetics Announces Public Stock Offering and Amended Credit Agreement (3 articles)